Early results indicate acceptable safety and promising efficacy of venetoclax in combination with pola-R-CHP for untreated high-risk BCL-2-positive B-cell lymphoma including double/triple hit lymphoma Meeting Abstract


Authors: Zelenetz, A. D.; Diefenbach, C. S.; Herbaux, C.; Tani, M.; Houot, R.; Bastos-Oreiro, M.; Tilly, H.; Gastinne, T.; Thieblemont, C.; Troy-Barnes, E.; Olivieri, S.; Kesavan, M.; Kanwar, M.; Barlera, S.; Hatzi, K.; Jiang, Y. W.; Boyer, M.; Morschhauser, F.
Abstract Title: Early results indicate acceptable safety and promising efficacy of venetoclax in combination with pola-R-CHP for untreated high-risk BCL-2-positive B-cell lymphoma including double/triple hit lymphoma
Meeting Title: 65th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 142
Issue: Suppl. 1
Meeting Dates: 2023 Dec 9-12
Meeting Location: San Deigo, CA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2023-11-02
Start Page: 439
Language: English
ACCESSION: WOS:001159306701196
DOI: 10.1182/blood-2023-174855
PROVIDER: wos
Notes: Meeting Abstract -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Andrew D Zelenetz
    767 Zelenetz
Related MSK Work